Hims & Hers Health Files 8-K on Agreements and Equity

TL;DR

HIMS dropped an 8-K: new deals, debt, and stock sales. Watch this space.

AI Summary

Hims & Hers Health, Inc. filed an 8-K on May 13, 2025, reporting on several key events. These include entering into a material definitive agreement, creating a direct financial obligation, and unregistered sales of equity securities. The filing also contains financial statements and exhibits.

Why It Matters

This 8-K filing indicates new financial obligations and potential equity issuances for Hims & Hers, which could impact its financial structure and shareholder equity.

Risk Assessment

Risk Level: medium — The filing details new financial obligations and unregistered equity sales, which can introduce financial and dilution risks.

Key Players & Entities

• Hims & Hers Health, Inc. (company) — Registrant
• May 13, 2025 (date) — Date of Report
• Delaware (jurisdiction) — State of Incorporation
• 001-38986 (identifier) — Commission File Number
• 2269 Chestnut Street, #523 San Francisco, CA 94123 (address) — Business Address

FAQ

From the Filing

0001193125-25-118948.txt : 20250513 0001193125-25-118948.hdr.sgml : 20250513 20250513172344 ACCESSION NUMBER: 0001193125-25-118948 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 22 CONFORMED PERIOD OF REPORT: 20250513 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250513 DATE AS OF CHANGE: 20250513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hims & Hers Health, Inc. CENTRAL INDEX KEY: 0001773751 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38986 FILM NUMBER: 25941473 BUSINESS ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 BUSINESS PHONE: 415-851-0195 MAIL ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 FORMER COMPANY: FORMER CONFORMED NAME: Oaktree Acquisition Corp. DATE OF NAME CHANGE: 20190412 8-K 1 d921356d8k.htm 8-K 8-K false 0001773751 0001773751 2025-05-13 2025-05-13     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2025     HIMS & HERS HEALTH, INC. (Exact name of registrant as specified in its charter)       Delaware   001-38986   98-1482650 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) 2269 Chestnut Street , #523 San Francisco , CA 94123 (Address of principal executive offices) (415) 851-0195 (Registrant’s telephone number, including area code)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol   Name of each exchange on which registered Class A Common Stock, $0.0001 par value   HIMS   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Explanatory Note Purchase Agreement On May 8, 2025, Hims & Hers Health, Inc. (the “ Company ”) entered into a purchase agreement (the “ Purchase Agreement ”) with Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC, as representatives of the several purchasers named therein (collectively, the “ Initial Purchasers ”), relating to the sale by the Company of an aggregate of $87